Abstract
This supplement benchmarks the status of population‐based survival for 10 leading cancers in the United States just prior to the implementation of the Patient Protection and Affordable Care Act. Overall survival in the United States is among the highest in the world; however, large racial disparities persist and health equity has been elusive. Further improvements in survival may be observed in the era of personalized cancer care and targeted therapies, and as federal and state initiatives seek to improve patient access to timely, effective therapies and care.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
